Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised Trial of Contrast-enhanced Sonothrombolysis in Acute Ischaemic Stroke (NOR-SASS)
2012-000323-41Phase 4Completed
- Sponsor
- Helse Bergen
- Start
- Apr 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of sulfur hexafluoride, tissue-plasminogen activator and tenecteplase in ischemic stroke and brain infarction (2 arms), sponsored by Helse Bergen. Primary endpoint: Periodic safety review. Started Apr 2012; status: completed.
02
Drugs
sulfur hexafluoridetissue-plasminogen activatortenecteplase
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on 2012-000323-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000323-41.